Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHilton Foods Regulatory News (HFG)

Share Price Information for Hilton Foods (HFG)

Share Price is delayed by 15 minutes
Get Live Data
510.00    2.00 (0.39%)
Bid:
509.50
Ask:
510.50
Spread: 1.00 (0.196%)
Market Cap: £458.77m
HFG Live PriceLast checked at - London Stock Exchange

Intraday Hilton Foods Share Chart

Director/PDMR Shareholding

11 May 2010 07:00

RNS Number : 6677L
Hilton Food Group PLC
10 May 2010
Β 

ο»Ώ

Hilton Food Group PLC

10 May 2010

ο»ΏNOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).

Β 

(1)

AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should completeΒ boxes 1 to 16, 23 and 24.

(2)

AnΒ issuerΒ making a notification in respect of a derivative relatingΒ toΒ theΒ sharesΒ of theΒ issuerΒ should completeΒ boxes 1 to 4, 6, 8,Β 13, 14, 16, 23 and 24.Β 

(3)

AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should completeΒ boxes 1 to 3Β and 17 to 24.Β 

(4)

AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β 

Β 

Please complete all relevant boxes in block capital letters.

Β 

1.Β Name of theΒ issuer

Hilton Food Group PLC

Β 

2.Β State whether the notification relates to (i) a transaction notified in accordance withΒ DRΒ 3.1.4R(1)(a); or

(ii)Β DRΒ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; orΒ 

(iii) both (i) and (ii)

(I)

Β 

3.Β Name ofΒ person discharging managerial responsibilities/director

R Watson

C Patten

P HefferΒ 

TΒ Bergman

N MajewskiΒ 

Β 

4.Β State whether notification relates to a personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

As per 3 above

5.Β Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

As per 3 above

6.Β Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

Ordinary shares of 10p each

7.Β Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

N/A

8Β State the nature of the transaction

Grant of Options (seeΒ boxΒ 17Β below)

9.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

………………………………

Β 

10.Β Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

………………………………

Β 

11.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

………………………………

Β 

12.Β Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β 

………………………………

Β 

13.Β Price perΒ shareΒ or value of transaction

………………………………

Β 

14.Β Date and place of transaction

………………………………

Β 

15.Β Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)

………………………………

Β 

16.Β Date issuer informed of transaction

………………………………

Β 

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

Β 

17Β Date of grant

10th May 2010

Β 

18.Β Period during which or date on which it can be exercised

10th May 2013 to 10th May 2020 provided the performance condition is met

Β 

19.Β Total amount paid (if any) for grant of the option

Nil

20.Β Description ofΒ sharesΒ or debentures involved (classΒ and number)

No. of share options granted

Ordinary shares of 10p each R Watson 130,610 C Patten 104,488 P Heffer 104,488 TΒ Bergman 113,610 N Majewski 104,488

Β Β 

Β 21.Β Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

246.00p

Β 

22.Β Total number ofΒ sharesΒ or debentures over whichΒ options heldΒ following notification

holding % R Watson 461,244 0.66 C Patten 368,995 0.53 P Heffer 368,995 0.53 TΒ Bergman 388,662 0.56 N Majewski 368,995 Β  0.53

23.Β Any additional information

Performance condition is that the average % annual increase in Earnings per Share for the 3 years 2010-2012 inclusive must be at least 3% more than the average % changeΒ in RPI.

24.Β Name of contact and telephone number for queries

Neil George,Β 

Company Secretary

+44 (0) 1480 387207

Β 

Name and signature of duly authorised officer ofΒ issuerΒ responsible for making notification

Neil George

Β 

Date of notification

10 May 2010

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSVBLFFBEFFBBF
Date   Source Headline
27th May 20268:22 amRNSDirectorate change
19th May 20264:00 pmRNSResult of AGM
19th May 20267:00 amRNSAGM Trading Update
28th Apr 20264:54 pmRNSHolding(s) in Company
16th Apr 20266:01 pmRNSAnnual Financial Report & Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20263:53 pmRNSHolding(s) in Company
31st Mar 20267:01 amRNSDirectorate change
31st Mar 20267:00 amRNSPreliminary Results
2nd Feb 20267:00 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNS2025 Full Year Trading Update
8th Jan 20267:00 amRNSBoard and Senior Leadership Changes
2nd Jan 202612:25 pmRNSTotal Voting Rights
2nd Jan 202612:19 pmRNSBlock listing Interim Review
2nd Dec 20252:14 pmRNSNotification of Dealing Form
25th Nov 20257:00 amRNSDirectorate Change
13th Nov 20254:02 pmRNSHolding(s) in Company
12th Nov 20257:00 amRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
23rd Oct 20257:00 amRNSNotification of major holdings
10th Oct 20252:39 pmRNSDirector/PDMR Shareholding
1st Oct 20256:30 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSSale of Fairfax Meadow Europe Limited
3rd Sep 20257:00 amRNSInterim Results
6th Aug 20253:19 pmRNSHolding(s) in Company
5th Aug 20252:43 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSStrategic External Investment
14th Jul 20252:50 pmRNSAdditional Listing
2nd Jul 20259:50 amRNSBlock listing Interim Review
20th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20253:26 pmRNSHolding(s) in Company
27th May 20252:22 pmRNSDirector/PDMR Shareholding
20th May 20253:57 pmRNSResult of AGM
20th May 20257:00 amRNSBoard Changes
20th May 20257:00 amRNSAGM Trading Update
13th May 20253:44 pmRNSDirector/PDMR Shareholding
6th May 20253:15 pmRNSTotal Voting Rights
28th Apr 20259:36 amRNSHolding(s) in Company
23rd Apr 20255:16 pmRNSDirector/PDMR Shareholding
22nd Apr 20251:56 pmRNSAnnual Financial Report
8th Apr 20253:48 pmRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSPreliminary Results
6th Mar 20257:00 amRNSChange in Senior Independent Director
6th Mar 20257:00 amRNSHILTON FOODS SIGNS JOINT VENTURE WITH NADEC
26th Feb 20254:14 pmRNSHolding(s) in Company
29th Jan 20253:21 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSFull Year Trading Update
2nd Jan 202511:51 amRNSBlock listing Interim Review
2nd Jan 202511:47 amRNSTotal Voting Rights
2nd Jan 202511:35 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.